Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLilly(Eli) & Co Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 14 | $6.52 | $7.46 | $6.97 |
| Q2 2026 | 13 | $8.51 | $9.06 | $8.81 |
| Q3 2026 | 12 | $8.90 | $10.49 | $9.40 |
| Q4 2026 | 10 | $9.50 | $10.58 | $9.89 |
| Q1 2027 | 5 | $8.81 | $9.82 | $9.18 |
| Q2 2027 | 5 | $9.92 | $11.06 | $10.33 |
| Q3 2027 | 5 | $10.67 | $11.89 | $11.11 |
| Q4 2027 | 5 | $8.70 | $9.69 | $9.06 |
Lilly(Eli) & Co Earnings Date And Information
Lilly(Eli) & Co last posted its earnings results on Thursday, April 30th, 2026. The company reported $8.55 earnings per share for the quarter, topping analysts' consensus estimates of $6.97 by $1.58. The company had revenue of 19.80 B for the quarter and had revenue of 65.18 B for the year. Lilly(Eli) & Co has generated $23 earnings per share over the last year ($22.95 diluted earnings per share) and currently has a price-to-earnings ratio of 39.14. Lilly(Eli) & Co has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Lilly(Eli) & Co Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/30/2026 | Q1 2026 | $6.97 | $8.27 | 1.3 | $17.82 B | $19.80 B |
| 02/12/2026 | Q4 2025 | N/A | $7.41 | N/A | $17.94 B | $19.29 B |
| 10/30/2025 | Q3 2025 | $5.69 | $6.22 | 0.53 | $16.05 B | $17.60 B |
| 08/07/2025 | Q2 2025 | $5.60 | $6.30 | 0.7 | $14.70 B | $15.56 B |
| 05/01/2025 | Q1 2025 | $3.26 | $3.07 | -0.19 | $12.67 B | $12.73 B |
| 02/19/2025 | Q4 2024 | N/A | $4.91 | N/A | $13.47 B | $13.53 B |
| 10/30/2024 | Q3 2024 | $1.47 | $1.08 | -0.39 | $12.10 B | $11.44 B |
| 08/08/2024 | Q2 2024 | $2.60 | $3.29 | 0.69 | $9.98 B | $11.30 B |
| 04/30/2024 | Q1 2024 | $2.46 | $2.49 | 0.03 | $8.94 B | $8.77 B |
| 02/21/2024 | Q4 2023 | N/A | $2.43 | N/A | N/A | $9.35 B |
| 11/02/2023 | Q3 2023 | -$0.08 | -$0.06 | 0.02 | N/A | $9.50 B |
| 08/08/2023 | Q2 2023 | $1.98 | $1.86 | -0.12 | N/A | $8.31 B |
| 04/27/2023 | Q1 2023 | $1.73 | $1.42 | -0.31 | N/A | $6.96 B |
| 02/22/2023 | Q4 2022 | N/A | $2.04 | N/A | N/A | $7.30 B |
| 11/01/2022 | Q3 2022 | $1.92 | $1.61 | -0.31 | N/A | $6.94 B |
| 08/04/2022 | Q2 2022 | $1.69 | $1.06 | -0.63 | N/A | $6.49 B |
| 04/29/2022 | Q1 2022 | N/A | $2.00 | N/A | N/A | $7.81 B |
| 02/23/2022 | Q4 2021 | N/A | $1.81 | N/A | N/A | $8.00 B |
| 10/27/2021 | Q3 2021 | N/A | $1.16 | N/A | N/A | $6.77 B |
| 08/03/2021 | Q2 2021 | $1.89 | $1.53 | -0.36 | N/A | $6.74 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lilly(Eli) & Co Earnings: FAQ's
In the previous quarter, Lilly(Eli) & Co (:LLY) reported $8.55 earnings per share (EPS) to beat the analysts' consensus estimate of $6.97 by $1.58.
The conference call for Lilly(Eli) & Co's latest earnings report can be listened to online.
The conference call transcript for Lilly(Eli) & Co's latest earnings report can be read online.
Lilly(Eli) & Co (:LLY) has a recorded annual revenue of $65.18 B.
Lilly(Eli) & Co (:LLY) has a recorded net income of $20.64 B.Lilly(Eli) & Co has generated $23 earnings per share over the last four quarters.
Lilly(Eli) & Co (:LLY) has a price-to-earnings ratio of 39.14 and price/earnings-to-growth ratio is 0.3.